Rein Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | |||
EBITDA | -6,870 | -5,609 | -5 | -6 |
EBIT | -6,871 | -5,797 | -5,797 | 5,722 |
Net Income | -6,822 | -5,501 | -40,981 | -5 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,418 | -6,175 | -4,812 | -3,819 |
Cash | 5,722 | 7,428 | 12,865 | 17,652 |
Basic Shares | 24,187 | 2 | 21 | 21 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -63 | |||
EBITDA | -28,049 | -15 | -27 | -26 |
EBIT | -28,112 | -15 | -27 | -26 |
Net Income | -62,883 | -15 | -27 | -26 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,291 | -19,808 | -24,865 | -23,911 |
Cash | 12,865 | 17,313 | 5,194 | 3,600 |
Basic Shares | 17 | 4 | 4 | 4 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.28 |
2025-03-31 | -$0.25 |
2024-09-30 | -$0.27 |
2024-06-30 | -$0.45 |
